This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Melinta Subsidiary Corp.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Jeffrey S. Loutit
Introduction
Jeffrey S. Loutit is a notable inventor based in Los Altos, California. He has made significant contributions to the field of medicine, particularly in the treatment of bacterial infections. His innovative approach has the potential to improve the lives of many immunocompromised patients.
Latest Patents
Loutit holds a patent for "Methods of treating bacterial infections." This patent focuses on treating bacterial infections in immunocompromised subjects and those with underlying malignancies. The method involves administering a combination of meropenem and vaborbactam to suitable subjects, including those with a history of leukemia or lymphoma, organ transplants, or those receiving immunosuppressive medications. This innovative treatment could greatly benefit patients suffering from neutropenia or malignancies.
Career Highlights
Throughout his career, Loutit has worked with prominent companies in the pharmaceutical industry, including Melinta Subsidiary Corp. and Melinta Therapeutics, Inc. His work has been instrumental in advancing medical treatments and improving patient outcomes.
Collaborations
Loutit has collaborated with esteemed colleagues such as Elizabeth Alexander and Michael N. Dudley. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective medical solutions.
Conclusion
Jeffrey S. Loutit's contributions to the field of medicine through his innovative patent and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in treating bacterial infections in vulnerable populations.